Showing 1 - 8 results of 8 for search '"fibrinolysis"', query time: 0.03s Refine Results
  1. 1
    Major mechanisms maintaining the regulation of hemostasis

    Major mechanisms maintaining the regulation of hemostasis by Ramazan Çöl, Zafer Durgun

    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Lipoprotein(a) and thromboembolism: current state of knowledge and unsolved issues

    Lipoprotein(a) and thromboembolism: current state of knowledge and unsolved issues by Małgorzata Konieczyńska, Joanna Natorska, Michał Ząbczyk, Anetta Undas

    Published 2024-12-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Viscoelastic Study of Hemostasis Disorders Associated with <i>Echis ocellatus</i> Envenoming in North Benin Using a Quantra Analyzer

    Viscoelastic Study of Hemostasis Disorders Associated with <i>Echis ocellatus</i> Envenoming in North Benin Using a Quantra Analyzer by Sébastien Larréché, Roland Benes Chacha, Noé Sodjinou, Seidou Alassane Ouorou, Eric Ganhouingnon, Edith Aloukoutou Layo, Bruno Mégarbane, Achille Massougbodji, Jean-Philippe Chippaux

    Published 2024-12-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Composición del trombo e implicaciones en la caracterización y el tratamiento en el ictus isquémico

    Composición del trombo e implicaciones en la caracterización y el tratamiento en el ictus isquémico by J. Marta-Enguita, F.J.D. Machado, J. Orbe, R. Muñoz

    Published 2025-01-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    The diagnosis of DIC: a current overview

    The diagnosis of DIC: a current overview by Hongyu Yang, Xiaochun Ma, Xu Li

    Published 2025-01-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Effect over coagulation and fibrinolysis parameters of a prolonged release 24 + 4 daily use regime contraceptive formulation containing 2 mg dienogest/0.02 mg ethinylestradiol

    Effect over coagulation and fibrinolysis parameters of a prolonged release 24 + 4 daily use regime contraceptive formulation containing 2 mg dienogest/0.02 mg ethinylestradiol... by Pedro-Antonio Regidor, Alicyoy Angulo, Enrico Colli

    Published 2025-12-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Optimal timing of pharmacoinvasive strategy and its impact on clinical and economic outcomes in patients with ST-elevation myocardial infarction: a real-world perspective

    Optimal timing of pharmacoinvasive strategy and its impact on clinical and economic outcomes in patients with ST-elevation myocardial infarction: a real-world perspective by Andrea Dias Stephanus, Alice Pacheco Santos, Ana Carolina Machado Rodrigues da Cunha, Ana Carolina Augusto Rocha, Amanda de Amorim Meireles, Mariana Guimarães Souza de Oliveira, Pietra Arissa Coelho Matsunaga, Alexandre Anderson de Sousa Munhoz Soares, Alexandre Anderson de Sousa Munhoz Soares, Ana Claudia Cavalcante Nogueira, Ana Claudia Cavalcante Nogueira, Ana Claudia Cavalcante Nogueira, Ana Claudia Cavalcante Nogueira, Adriana de J. B. de Almeida Guimarães, Adriana de J. B. de Almeida Guimarães, Gustavo de Almeida Alexim, Alessandra M. Campos-Staffico, Luiz Sergio Fernandes de Carvalho, Luiz Sergio Fernandes de Carvalho, Luiz Sergio Fernandes de Carvalho

    Published 2025-01-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Interdependence of coagulation with immunotherapy and BRAF/MEK inhibitor therapy: results from a prospective study

    Interdependence of coagulation with immunotherapy and BRAF/MEK inhibitor therapy: results from a prospective study by Malte Beckmann, Julian Schlüter, Michael Erdmann, Rafaela Kramer, Sarah Cunningham, Holger Hackstein, Robert Zimmermann, Lucie Heinzerling

    Published 2024-11-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: